| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technical Officer
1 company
Osborne David W is a Chief Technical Officer at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $7.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 690 | $15.26 | $10,531.75 | -0.3% | -41.1% | -25.0% | |
| Mar 2, 2023 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 2,005 | $15.96 | $32,002.07 | -0.3% | -52.5% | -25.6% | |
| Jul 8, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 2,197 | $25.41 | $55,835.44 | -0.8% | -22.4% | -63.7% | |
| Apr 21, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 2,197 | $20.42 | $44,872.19 | -0.8% | +19.1% | -31.7% | |
| Mar 7, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 856 | $16.85 | $14,419.79 | -0.2% | +24.5% | -17.1% | |
| Mar 1, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 775 | $17.75 | $13,758.34 | -0.3% | +19.3% | -4.6% | |
| Mar 1, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 780 | $34.57 | $26,967.72 | -0.3% | -21.6% | -50.0% | |
| Dec 14, 2020 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 15,000 | $30.00 | $450,000.00 | -5.6% | - | - | |
| Sep 29, 2020 | ARQT Arcutis Biotherapeutics, Inc. | Chief Technical Officer | Sell | 15,000 | $30.00 | $450,000.00 | -5.4% | - | - |